Anti-angiogeneic target therapy for cancer with vaccine based on the recombinant chicken FGFR-1 in tumor-bearing mice

Abstract

To explore the anti-tumor effect of immunotherapy with recombinant protein vaccine based on FGFR-1 of chicken (cFR-1) in a mouse Meth A fibrosarcoma model, tumor volume and survival rate of the mice were observed at a 3-day interval. Microvessel density (MVD) was detected by immunohistochemistry. Auto-antibodies against self-FGFR-1 were detected by Western blotting and ELISA, respectively. The anti-FGFR-1 antibody-producing B cells (APBCs) were detected by enzyme-linked immunospot (ELISPOT) assay. Eighteen days after inoculation of tumor cells, the tumor volume was significantly smaller in cFR-1-immunized group than in mouse FGFR-1 (mFR-1) immunized group and normal saline (NS) control group (P<0.05), and the survival time was significantly longer in cFR-1-immunized group than in the control groups (P<0.01). MVD was significantly lower in cFR-1-immunized group than in mFR-1-immunized group and NS group (16.8±5.6 vs 64.6±1.8 and 59.6±8.7, P<0.01). Antibodies against self-FGFR-1 were found in mFR-1-immunized group, the major antibody subclasses were IgG1 and IgG2b. Compared with the two control groups, the numbers of APBCs in cFR-1-immunized group were significantly increased (P<0.01) These results demonstrated that the cFR-1-related anti-angiogenesis protein vaccine could induce the production of auto-antibodies against self-FGFR-1, which futher inhibit angiogenesis and growth of solid tumor.

Keywords

fibroblast growth factor receptor-1 / vaccine / anti-angiogenesis / fibrosarcoma / immunotherapy

References

[1] FolkmanJ.. Angiogenesis-dependent diseases. Semin Oncol, 2001, 28(6): 536-542

[2] PowersC. J., McleskeyS. W., WellsteinA.. Fibroblast growth factors, their receptors and signaling. Endocine-Related Cancer, 2000, 7: 165-197

[3] KlintP., Claesson-WelshL.. Signal transduction by fibroblast growth factor receptors. Front Biosci, 1999, 15: 165-177

[4] ChaudhuriM. M., MoscatelliD., BasilicoC.. Involvement of the conserved acidic amino acid domain of FGF receptor 1 in ligand- receptor interactions. J Cell Physiol, 1993, 157: 209-216

[5] ValeskyM., SpangA. J., FisherG. W.. Noninvasive dynamic fluorescence Imaging of human melanomas reveals that targeted Inhibition of bFGF or FGFR-1 in melanoma cells blocks tumor growth by apoptosis. Mol Med, 2002, 8(2): 103-111

[6] WangF., McKeehanK., YuC. D., et al.. Fibroblast growth factor receptor 1 phosphotyrosine 766:molecular target for prevention of progression of prostate tumors to malignancy. Cancer Res, 2002, 62(6): 1898-1903

[7] UdayakumarT. S., KleinR. D., MalinerM. S., et al.. Aberrant expression of fibroblast growth factor receptor-1 in prostate epithelial cells allows induction of promatrilysin expression by fibroblast growth factors. Int J Cancer, 2001, 91(2): 187-192

[8] BlanckaertV. D., VenkateswaranS., HanI. S., et al.. Partial characterization of endothelial FGF receptor functional domain by monoclonal antibody VBS-1. Hybrid Hybridomics, 2002, 21(3): 153-159

[9] RoopaS., JeddD. W.. Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines. J Transl Med, 2004, 2(1): 12-23

[10] GregorP. D., WolchokJ. D., TuragaV., et al.. Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination. Int J Cancer, 2005, 116(3): 415-421

[11] ZhengS. J., HuangF. Y., ZhengS. P., et al.. Vaccination with a recombinant chicken FGFR-1 bypasses immunological tolerance against self-FGFR-1 in mice. J Huazhong Univ Sci Technolog [Med Sci], 2006, 26(4): 389-391

[12] ZhengS. J., HuangF. Y., ZhengS. P., et al.. Construction and identifiction of recombinant plasmid encoding extracellular domain of FGFR1 in Chicken. J Huazhong Univer Sci Technol [Med] (Chinese), 2006, 35(4): 433-435

[13] JiangH., WuH. M., ZhuP. C., et al.. Relationship between lymphatic metastasis and expression of C-met proto-oncogene and microvessel density lung cancer. US Chin J Lymphol Oncol, 2003, 2(3): 6-10